Search

Author/Creator Cheng, Andrew K

1. Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial. Issue 4 (April 2016)

Authors:
Gallant, Joel E; Daar, Eric S; Raffi, François; Brinson, Cynthia; Ruane, Peter; DeJesus, Edwin; Johnson, Margaret; Clumeck, Nathan; Osiyemi, Olayemi; Ward, Doug; Morales-Ramirez, Javier; Yan, Mingjin; Abram, Michael E; Plummer, Andrew; Cheng, Andrew K; Rhee, Martin S
Journal:
Lancet
Issue:
Volume 3:Issue 4(2016)
Page Start:
e158
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study. Issue 1 (January 2016)

Authors:
Mills, Anthony; Arribas, Jose R; Andrade-Villanueva, Jaime; DiPerri, Giovanni; Van Lunzen, Jan; Koenig, Ellen; Elion, Richard; Cavassini, Matthias; Madruga, Jose Valdez; Brunetta, Jason; Shamblaw, David; DeJesus, Edwin; Orkin, Chloe; Wohl, David A; Brar, Indira; Stephens, Jeffrey L; Girard, Pierr...
Journal:
Lancet infectious diseases
Issue:
Volume 16:Issue 1(2016:Jan.)
Page Start:
43
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials. Issue 9987 (27th June 2015)

Authors:
Sax, Paul E; Wohl, David; Yin, Michael T; Post, Frank; DeJesus, Edwin; Saag, Michael; Pozniak, Anton; Thompson, Melanie; Podzamczer, Daniel; Molina, Jean Michel; Oka, Shinichi; Koenig, Ellen; Trottier, Benoit; Andrade-Villanueva, Jaime; Crofoot, Gordon; Custodio, Joseph M; Plummer, Andrew; Zhong,...
Journal:
Lancet
Issue:
Volume 385:Issue 9987(2015)
Page Start:
2606
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Week 144 Resistance Analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF versus Efavirenz/Emtricitabine/Tenofovir DF in Antiretroviral-Naive Patients. Issue 3 (April 2015)

Authors:
White, Kirsten L; Kulkarni, Rima; McColl, Damian J; Rhee, Martin S; Szwarcberg, Javier; Cheng, Andrew K; Miller, Michael D
Journal:
Antiviral therapy
Issue:
Volume 20:Issue 3(2015)
Page Start:
317
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗